Bipolar disorder in women

Psychiatric Annals

Volumn 32, Issue 7, 2002, Pages 397-404

  Amsterdam, Jay D ^a,b   Brunswick, David J ^a   O'Reardon, John ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b The Science Center Philadelphia   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CARBAMAZEPINE; CORTICOTROPIN; DEXAMETHASONE; ESTROGEN; FLUOXETINE; HORMONE; HYDROCORTISONE; LIOTHYRONINE; LITHIUM; PSYCHOTROPIC AGENT; SEROTONIN UPTAKE INHIBITOR; THYROXINE; TRICYCLIC ANTIDEPRESSANT AGENT; VALPROIC ACID; VENLAFAXINE;

ALCOHOLISM; BIPOLAR DEPRESSION; BIPOLAR DISORDER; CLIMACTERIUM; COMORBIDITY; CYANOSIS; DEPRESSION; DIAGNOSTIC ERROR; DISEASE PREDISPOSITION; DISTRACTIBILITY; DRUG EFFICACY; DRUG EXPOSURE; DRUG MEGADOSE; DYSPHORIA; EBSTEIN ANOMALY; EMOTIONAL DISORDER; ENDOCRINE DISEASE; EPIDEMIOLOGICAL DATA; ESTROGEN THERAPY; EUPHORIA; FACE MALFORMATION; FETOTOXICITY; GENDER; GRANDIOSE DELUSION; HEALTH SURVEY; HEPATOMEGALY; HUMAN; HYPERACTIVITY; HYPERTHYROIDISM; HYPOMANIA; HYPOTHALAMUS HYPOPHYSIS ADRENAL SYSTEM; HYPOTHYROIDISM; INFANTILE HYPOTONIA; MAJOR DEPRESSION; MANIA; MENOPAUSE; MENSTRUAL CYCLE; MENTAL HEALTH; MIXED MANIA AND DEPRESSION; MONOTHERAPY; MOOD DISORDER; MUSCLE HYPOTONIA; NEURAL TUBE DEFECT; PHENOMENOLOGY; PREGNANCY; PREVALENCE; RAPID CYCLING BIPOLAR DISORDER; REVIEW; SUICIDAL BEHAVIOR; TERATOGENICITY; THYROID FUNCTION; TOXICITY;

EID: 0242288114     PISSN: 00485713     EISSN: None     Source Type: Journal    
DOI: 10.3928/0048-5713-20020701-07     Document Type: Review

References (81)

1. Akiskal HS. The prevalent clinical spectrum of bipolar disorders: beyond DSM-IV. J Clin Psychopharmacol. 1996;16 (suppl 1):4S-14S.
2. Benazzi F. Prevalence of bipolar II disorder in outpatient depression: a 203-case study in private practice. J Affect Disord. 1997;43:163-166.
3. Goodwin FK, Jamison KR. Manic Depressive Illness. New York, NY: Oxford University Press; 1990.
4. Weissman MM, Leaf PJ, Tischler GL, et al. Affective disorders in five United States communities. Psychol Med. 1988;18:141-153.
5. Tohen M, Goodwin FK. Epidemiology of bipolar disorder. In: Tsuang M, Tohen M, Zahner G, eds. Textbook of Psychiatric Epidemiology. New York, NY: Wiley-Liss; 1995:301-316.
6. Robins LN, Regier DA. Psychiatric Disorders in America: The Epidemiologic Catchment Area Study. New York, NY: The Free Press; 1991.
7. Kessler R, McGonagle KA, Zhao S, et al. Life-time and 12-month prevalence of DSM III-R psychiatric disorders in the United States. Arch Gen Psychiatry. 1994;51:8-19.
8. Roy-Byrne P, Post RM, Uhde TW, Porcu T, Davis D. The longitudinal course of affective illness: life chart data from research patients at the NIMH. Acta Psychiatr Scand. 1985;71:(317, suppl):1-34.
9. Lish JD, Dime-Meenan S, Whybrow PC, Price RA, Hirschfeld RMA. The National Depressive and Manic-Depressive Association (DMDA) survey of bipolar members. J Affect Disord. 1994;31:281-294.
10. Taylor MA, Abrams R. Early- and late-onset bipolar illness. Arch Gen Psychiatry. 1981;38:58-61.
11. Yan SM, Luxi X. Early-onset and late-onset bipolar affective disorder: a study of heterogeneity. IRCS Medical Science - Biochemistry. 1985;13:328-329.
12. Leibenluft E. Women with bipolar illness: clinical and research issues. Am J Psychiatry. 1996;153:163-173.
13. Leibenluft E. Issues in the treatment of women with bipolar illness. J Clin Psychiatry. 1997;58(suppl 15):5-11.
14. Taschev T. The course and prognosis of depression on the basis of 652 patients deceased. In: Angst J, ed. Classification and Predication of Outcome of Depression. Stuttgart, Germany: FK Schattauer Verlag; 1973:157-172.
15. Angst J. The course of affective disorders, II: typology of bipolar manic-depressive illness. Archiv Fur Psychiatrie und Nervenkrankheiten. 1978;226:65-73.
16. Coryell W, Endicott J, Keller M. Rapidly cycling affective disorder. Demographics, diagnosis, family history, and course. Arch Gen Psychiatry. 1992;49:126-131.
17. Bauer MS, Whybrow PC, Winokur A. Rapid cycling bipolar affective disorder, I: association with grade I hypothyroidism. Arch Gen Psychiatry. 1990;47:427-432.
18. McElroy SL, Keck PE, Pope HG, Hudson JI, Faedda GL, Swann AC. Clinical and research implications of the diagnosis of dysphoric or mixed mania or hypomania. Am J Psychiatry. 1992;149:1633-1644.
19. Wehr TA, Goodwin FK. Can antidepressants cause mania and worsen the course of affective illness? Am J Psychiatry. 1987;144:1403-1411.
20. Wehr TA, Sack MD, Rosenthal NE, Cowdry RW. Rapid cycling affective disorder: contributing factors and treatment responses in 51 patients. Am J Psychiatry. 1998;145:179-184.
21. Cassidy F, Murry E, Forest K, Carroll BJ. Signs and symptoms of mania in pure and mixed episodes. J Affect Disord. 1998;50:187-201.
22. Akiskal HS, Hantouche EG, Bourgeois ML, et al. Gender, temperament, and the clinical picture in dysphoric mixed mania: findings from a French national study (EPIMAN). J Affect Disord. 1998;50:175-186.
23. Goldberg JF, Gamo JL, Leon AC, Kocsis JH, Portera L. Association of recurrent suicidal ideation with nonremission from acute mixed mania. Am J Psychiatry. 1998;155:1753-1755.
24. Dunner DL. Sub-types of bipolar affective disorder with particular regard to bipolar II. Psychiatric Developments. 1983;1:75-85.
25. Endicott J, Nee J, Andreasen N, Clayton P, Keller M, Coryell W. Bipolar II: combine or keep separate? J Affect Disord. 1985;8:17-28.
26. Kupfer DJ, Carpenter LL, Frank E. Possible role of antidepressants in precipitating mania and hypomania in recurrent depression. Am J Psychiatry. 1988;145:804-808.
27. Regier DA, Farmer ME, Rae DS, et al. Comorbidity of mental health disorders with alcohol and other drug abuse. JAMA. 1990;264:2511-2518.
28. Ayuso-Gutierrez JL, Ramos-Brieva JA. The course of manic-depressive illness. A comparative study of bipolar I and bipolar II patients. J Affect Disord. 1982;4:9-14.
29. Coryell W, Endicott J, Maser JD, Keller MB, Leon AC, Akiskal HS. Long-term stability of polarity distinctions in the affective disorders. Am J Psychiatry. 1995;152:385-390.
30. Winokur G, Coryell W, Keller M, Endicott J, Akiskal H. A prospective follow-up of patients with bipolar and primary unipolar affective disorder. Arch Gen Psychiatry. 1993;50:457-465.
31. Simpson SG, Folstein SE, Meyers DA, McMahon FJ, Brusco DM, DePauo JR Jr. Bipolar II: the most common bipolar phenotype. Am J Psychiatry. 1993;150:901-903.
32. O'Connell RA, Mayo JA, Flatow L, Cuthbertson B. Outcome of bipolar disorder on long-term treatment with lithium. Br J Psychiatry. 1991;159:123-129.
33. Kupfer DJ, Carpenter LL, Frank E. Is bipolar II a unique disorder? Compr Psychiatry. 1988;29:228-236.
34. Akiskal HS, Cassano GB, Musetti L, Perugi G, Tundo A, Mignani V. Psychopathology, temperament, and past course in primary major depressions, I: review of evidence for a bipolar spectrum. Psychopathology. 1989;22:268-277.
35. Goodwin FK, Ghaemi SN. Understanding manic-depressive illness. Arch Gen Psychiatry. 1998;55:23-25.
36. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders. 4th ed. Washington, DC: American Psychiatric Association; 1994.
37. Tondo L, Baldessarini RJ. Rapid cycling in women and men with bipolar manic-depressive disorders. Am J Psychiatry. 1998;155:1434-1436.
38. Maj M, Magliano L, Pirozzi R, et al. Validity of rapid cycling as a course specifier for bipolar disorder. Am J Psychiatry. 1994;151:1015-1019.
39. Amsterdam JD. Efficacy and safety of venlafaxine in bipolar type-II and unipolar major depressive disorder. J Clin Psychopharmacol. 1998;18:414-417.
40. Amsterdam JD, Garcia-Espana F, Fawcett J, et al. Efficacy and safety of fluoxetine in bipolar II major depressive episode. J Clin Psychopharmacol. 1998;18:435-440.
41. Amsterdam JD, Garcia-Espana F, Fawcett J, et al. Fluoxetine efficacy in menopausal women with and without estrogen replacement. J Affect Disord. 1999;55:11-17.
42. Prange AJ Jr, Mason GA, Garbutt JC. Thyroid axis syndromes in depression: definitions and interpretations. In: Amsterdam JD, ed. Pharmacotherapy of Depression. New York, NY: Marcel Dekker; 1990:35-56.
43. Bauer MS, Whybrow PC. Rapid cycling bipolar disorder: clinical features, treatment, and etiology. In: Amsterdam JD, ed. Refractory Depression. New York, NY: Raven Press; 1991:191-208.
44. Amsterdam JD, Winokur A, Lucki I, Caroff S, Snyder P, Rickels K, A neuroendocrine test battery in bipolar patients and healthy controls. Arch Gen Psychiatry. 1983;40:515-521.
45. Winokur A, Caroff S, Amsterdam JD, Maislin G. Administration of thyrotropin-releasing hormone at weekly intervals results in a diminished thyrotropin response. Biol Psychiatry. 1984;19:695-702.
46. Amsterdam JD, Maislin G, Winokur A, Phillips J, Berwish N, Gold P. The assessment of abnormalities in hormonal responsiveness at multiple levels of the hypothalamic-pituitary-adrenocortical axis in depressive illness. Psychoneuroendocrinology. 1989;14:43-62.
47. Amsterdam JD, Winokur A, Caroff S, Conn J. The dexamethasone suppression test in outpatients with primary affective disorder and healthy control subjects. Am J Psychiatry. 1982;139:284-291.
48. Caroff S, Winokur A, Rieger W, Schweizer E, Amsterdam J. Response to dexamethasone in psychotic depression. Psychiatry Res. 1983;8:59-64.
49. Evans DL, Nemeroff CB. The dexamethasone suppression test in mixed bipolar disorder. Am J Psychiatry. 1983;140:615-617.
50. Swann AC, Stokes PE, Casper R, et al. Hypothalamic-pituitary- adrenocortical function in mixed and pure mania. Acta Psychiatr Scand. 1992;85:270-274.
51. Loosen PT, Shelton RS. Thyroid hormones and antidepressant drugs. In: Amsterdam JD, ed. Pharmacotherapy of Depression. New York, NY: Marcel Dekker; 1990:241-253.
52. Joffe RT, Singer W. Thyroid hormone potentiation of antidepressants. In: Amsterdam JD, ed. Refractory Depression. New York, NY: Raven Press; 1991:185-190.
53. Chang KD, Keck PE Jr, Stanton SP, et al. Differences in thyroid function between bipolar manic and mixed states. Biol Psychiatry. 1998;43:730-733.
54. Kendell RE, Wainwright A, Shanon B. The influence of childbirth on psychiatric morbidity. Psychol Med. 1976;6:297-302.
55. Andersch B, Wendestam C, Hahn L, Ohman R. Premenstrual complaints, I: prevalence of premenstrual symptoms in a Swedish urban population. J Psychosom Obstet Gynaecol. 1986;5:39-49.
56. Anderson E, Hamburger S, Lin JH, Rebar RW. Characterization of menopausal women seeking assistance. Am J Obstet Gynecol. 1987;156:428433.
57. Dean C, Williams RJ, Brockington IF. Is puerperal psychosis the same as bipolar manic-depressive disorder? A family study. Psychol Med. 1989;19:637-647.
58. Gregoire AJP, Kumar R, Everitt B, Henderson AF, Studd JWW. Transdermal estrogen for treatment of severe postnatal depression. Lancet. 1996;347:930-933.
59. Ahokas A, Kaukoranta J, Wahlbeck K, Aito M. Estrogen deficiency in severe postpartum depression: successful treatment with sublingual physiologic 17β-estradiol: a preliminary study. J Clin Psychiatry. 2001;62:332-336.
60. Anthony AC, Aboraya A. The epidemiology of selected mental disorders in late life. In: Birren JE, Sloan RB, Cohen GD, eds. Handbook of Mental Health and Aging. 2nd ed. New York, NY: Academic Press; 1992.
61. Kessler RC, McGonagla KA, Swartz M, Blazer DG, Nelson CB. Sex and depression in the National Survey, I: lifetime prevalence, chronicity, and recurrence. J Affect Disord. 1993;29:85-96.
62. Sherwin BB, Gelfand MM. Sex steroid and affect in the surgical menopause: a double-blind, crossover study. Psychoneuroendocrinology. 1985;10:325-335.
63. Sherwin BB. Affective changes in estrogen and androgen replacement therapy in surgically menopausal women. J Affect Disord. 1988;14:177-187.
64. Klaiber EL, Broverman DM, Vogel W, Peterson LG, Snyder MB. Individual differences in changes in mood and platelet monoamine oxidase (MAO) activity during hormonal replacement therapy in menopausal women. Psychoneuroendocrinology. 1996;21:575-592.
65. Lippert TH, Filshie M, Muck AO, Seeger H, Zwirner M. Serotonin metabolite excretion after postmenopausal estradiol therapy. Maturitas. 1996;24:37-41.
66. Sherwin BB. Estrogen and refractory depression. In: Amsterdam JD, ed. Refractory Depression. New York, NY: Raven Press; 1991:209-218.
67. Schneider LS, Small GW, Hamilton SH, Bystrisky A, Nemeroff CB, Meyers BS. Estrogen replacement and response to fluoxetine in a multi-center geriatric depression trial. Am J Geriatr Psychiatry. 1997;5:97-106.
68. Zweifel JE, O'Brien WH. A meta-analysis of the effect of hormone replacement therapy upon depressed mood. Psychoneuroendocrinology. 1997;22:189-212._
69. Schneider MA, Brotherton PL, Hailes J. The effect of exogenous oestrogens on depression in menopausal women. Med J Aust. 1977;2:162-163.
70. Klaiber EL, Broverman DM, Vogel W, Kobayashi Y. Estrogen therapy for severe depressions in women. Arch Gen Psychiatry. 1979;36:550-554.
71. Soares CN, Almeida OP, Joffe H, Cohen LS. Efficacy of estradiol for the treatment of depressive disorders in perimenopausal women. Arch Gen Psychiatry. 2001;58:529-534.
72. Schmidt PJ, Nieman L, Danacau MA, et al. Estrogen replacement in perimenopause-related depression: a preliminary report. Am J Obstet Gynecol. 2000;183:414-420.
73. American Psychiatric Association. Practice guidelines for the treatment of patients with bipolar disorder. Am J Psychiatry. 1994;151(suppl):1-36.
74. Altshuler LL, Post RM, Leverich GS, Mikalauskas K, Rosoff A, Ackerman L. Antidepressant-induced mania and cycle acceleration: a controversy revisited. Am J Psychiatry. 1995;152:1130-1138.
75. Akiskal HS, Maser JD, Zeller PJ, et al. Switching from "unipolar" to bipolar II. An 11-year prospective study of clinical and temperamental predictors in 559 patients. Arch Gen Psychiatry. 1995;52:114-123.
76. Elia J, Simpson GM. Antidepressant medications during pregnancy and lactation: fetal teratogenidty and toxicity. In: Amsterdam JD, ed. Pharmacotherapy of Depression: Applications for the Outpatient Practitioner. New York, NY: Marcel Dekker; 1990:337-380.
77. Amsterdam JD, Garcia-Espana E Venlafaxine monotherapy In women with bipolar II depression. J Affect Disord. 2000;59:225-229.
78. Cohen LS, Friedman JM, Jefferson JW, et al. A reevaluation of risk of in utero exposure to lithium. JAMA. 1994;271:146-150.
79. Johnson EMJ. A summary review and human perspective for developmental toxicity evaluations on lithium in laboratory animals. In: Schrauzer GN, Klippel KF, eds. Lithium in Biology and Medicine: New Applications and Developments. Weinheim, Germany: VCH Verlagsgesellschaff; 1991:101-112.
80. Llewellyn A, Stowe ZN, Strader JR. The use of lithium and management of women with bipolar disorder during pregnancy and lactation. J Clin Psychiatry. 1998;59(suppl 6):57-64.
81. Troyer WA, Pereira GR, Lannon RA, Belik J, Yoder M. Association of maternal exposure and premature delivery. J Perinatol. 1993;12:123-127.